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Abstract
Background: Anxiety disorders in adolescence have been associated with several psychiatric outcomes. We sought
to describe the prospective relationship between various levels of adolescent anxiety and psychiatric diagnoses
(anxiety-, bipolar/psychotic-, depressive-, and alcohol and drug misuse disorders) and suicidal ideation in early
adulthood while adjusting for childhood attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder
(ASD), and developmental coordination disorder (DCD). Furthermore, we aimed to estimate the proportion
attributable to the various anxiety levels for the outcomes.
Methods: We used a nation-wide population-based Swedish twin study comprising 14,106 fifteen-year-old twins
born in Sweden between 1994 and 2002 and a replication sample consisting of 9211 Dutch twins, born between
1985 and 1999. Adolescent anxiety was measured with parental and self-report. Psychiatric diagnoses and suicidal
ideation were retrieved from the Swedish National Patient Register and via self-report.
Results: Adolescent anxiety, of various levels, predicted, in the Swedish National Patient Register, anxiety disorders:
hazard ratio (HR) = 4.92 (CI 3.33–7.28); depressive disorders: HR = 4.79 (3.23–7.08), and any psychiatric outcome:
HR = 3.40 (2.58–4.48), when adjusting for ADHD, ASD, and DCD. The results were replicated in the Dutch data. The
proportion of psychiatric outcome attributable to adolescent anxiety over time (age 15–21) was 29% for any
psychiatric outcome, 43–40% for anxiety disorders, and 39–38% for depressive disorders.
Conclusion: Anxiety in adolescence constitutes an important risk factor in the development of psychiatric
outcomes, revealing unique predictions for the different levels of anxiety, and beyond the risk conferred by
childhood ADHD, ASD, and DCD. Developmental trajectories leading into psychiatric outcomes should further
empirically investigated.
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Background
Anxiety disorders are an umbrella term for anxiety con-
structs, for example, social anxiety disorder and panic
disorder; and are the most prevalent psychiatric disor-
ders in the western world, with an estimated lifetime
prevalence up to 32% [1]. Anxiety disorders often have
their onset in childhood or adolescence and frequently
co-occur with each other and/or with later psychiatric
outcomes such as depression, substance use disorders,
and suicidal behavior [2]. In addition, childhood and
adolescence anxiety disorders are associated with several
adverse functional outcomes in adulthood, such as re-
duced life satisfaction, familial and social impairment,
educational underachievement and poor adjustment at
work [2, 3].
Existing studies aimed at investigating the relationship
of childhood or adolescent anxiety disorders and adverse
adult outcomes have shown robust associations with
later risks of adult anxiety-, affective-, substance use-,
and behavioral disorders, suicidal behavior, and psych-
otic symptoms [2–6]. These heterogeneous associations
are in line with the emerging concept of a common
underlying susceptibility for nearly all mental disorders
[7, 8]. In addition, while standardized assessments of
psychiatric disorders based on systems such as the Diag-
nostic and Statistical Manual of Mental Disorders [9] or
the International Classification of Diseases [10] are com-
monly used, accumulating evidence suggests that virtu-
ally all psychiatric disorders can best be conceptualized
as the extreme end of a dimensionally distributed trait
[11], and it is yet unclear how various levels of anxiety
are associated with psychiatric outcomes.
Crucially, most longitudinal studies focus on the spe-
cific effects of childhood or adolescent anxiety disorders
on subsequent psychiatric outcomes without considering
that youth anxiety may be confounded by neurodevelop-
mental disorders such as attention-deficit/hyperactivity
disorder (ADHD), autism spectrum disorder (ASD), and
developmental coordination disorder (DCD) earlier in
childhood. Co-existence between youth anxiety and
ADHD [12, 13], ASD [14], and DCD [15] are highly
common. Associations between these constructs and
psychiatric outcomes, e.g. ADHD and alcohol/substance
use disorders [16], or ASD and suicide [17], are consid-
erably stronger than those between anxiety disorders
and psychiatric outcomes. Additionally, there is a strong
relationship between ADHD and psychiatric disorders
that remains after adjustment for anxiety disorders [18].
Finally, neurological soft signs, together with anxious be-
havior in childhood, were found to be strongly predictive
of persistent psychiatric disorder [15], indicating a need
to examine the possible confounding of this relationship.
To conclude, current evidence strongly and robustly
suggests that youth anxiety disorders predict a broad
range of subsequent psychiatric outcomes. However, the
risk conferred by various levels of anxiety, as well as
ADHD, ASD, and DCD in childhood is yet unknown.
This study sought to describe the relationship between
different levels of adolescent anxiety and psychiatric
diagnoses in late adolescence/young adulthood: alcohol
and drug misuse disorders, anxiety disorders, bipolar/
psychotic disorders, depressive disorders, and suicidal
ideation in a population-based study of 14,106 Swedish
twins, replicated in an independent community-based
sample comprising 9211 Dutch twins. The specific aims
of the study were first, to estimate the association be-
tween various levels of adolescent anxiety and later psy-
chiatric diagnoses and suicidal ideation from service-
based registers and to test whether ADHD, ASD, and
DCD in childhood confound a possible association. Sec-
ond, to estimate the total amount of psychiatric out-
comes attributable to the various levels of adolescent
anxiety.
Method
Participants
We used two sources to examine the relationship be-
tween anxiety in adolescence and psychiatric outcomes
in late adolescence/young adulthood: the Child and
Adolescent Twin Study in Sweden (CATSS) and the
Swedish National Patient Register (NPR). In addition, we
conducted replication analyses on a longitudinal dataset
that was retrieved from the Netherlands Twin Register
(NTR).
Child and Adolescent Twin Study in Sweden
CATSS is an ongoing, longitudinal, population-based
study on somatic and mental health problems in
twins during childhood and adolescence. Details can
be found elsewhere [19]. Briefly, since 2004, parents
of all Swedish twins born from July 1992 and on-
wards are contacted in connection with the twins’
ninth or 12th birthday (CATSS-9/12) and asked to
participate in a telephone interview, which includes
measures of, among other things, neurodevelopmental
disorders. When the twins reach the age of 15
(CATSS-15), families are contacted again and asked
to fill out a web-based questionnaire, targeting vari-
ous mental health problems and social milieus.
CATSS-15 includes twins born from the first of January
1994 up until 2002. In the present study, we included 12,
324 twins who completed the self-reports at age 15, and
parental report covering 11,133 twins, out of which a total
of 85% (self-report) and 87% (parental report) had
complete data at age 9/12. A total of 14,106 twins where
covered with either self- or parental report.
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Measures
Anxiety in adolescence
CATSS-15 includes both the parental and self-report
version of the Strengths and Difficulties Questionnaire
(SDQ; [20]). The SDQ is a brief behavioral screening
questionnaire for children and adolescents between the
ages of 3 to 16 years. In the present study, the emotional
problems scale, parental and self-report, was used as an
indicator of anxiety in adolescence. The scale has 5
items with 3 response options: 0 (not true), 1 (somewhat
true), and 2 (certainly true). In addition to dimensional
scoring, three categories [20] have been proposed so that
roughly 80% of the children fall into a ‘normal’ (in the
present study scores between 0 and 2 in the parental re-
port, scores between 0 and 4 in the self-report), 10% into
a ‘borderline’ (i.e. score 3 in the parental report, score 5
in the self-report) and 10% into an ‘abnormal’ (i.e. ≥ 4 in
the parental report, ≥ 6 in the self-report) category. The
emotional problems scale has been reported to have a
sensitivity/specificity ranging between 29/96% (youth re-
port) to 54/91% (parent report) for anxiety disorders
[21] and correlates strongly with other measures of anx-
iety in youth [22]. In the present study, the Area Under
the Receiving Characteristics Curve for the scale was
0.67/0.69 when comparing parental/self-report to the
clinical diagnosis of anxiety disorder from the register
mentioned below. Studies of the Swedish version of the
SDQ symptom scales have confirmed the factor struc-
ture of the original English SDQ [23], and results from a
validation study of the Swedish SDQ indicate that the
parental version has a good discriminatory validity [24].
Neurodevelopmental disorders
The Autism-Tics, ADHD, and other Comorbidities in-
ventory (A-TAC [25]; is included in CATSS-9/12. The
A-TAC is a fully structured 96-item parent-report tele-
phone interview designed for large-scale epidemiological
purposes. To screen for neurodevelopmental disorders
in childhood, the A-TAC is based on symptom criteria
and common clinical features. Items are scored as 1
(yes), 0.5 (yes, to some extent), and 0 (no) and are di-
vided into modules corresponding to diagnostic do-
mains. Cross-sectional and longitudinal validation
studies show good to excellent predictive validity for,
amongst others, ADHD, ASD, and DCD [26, 27]. In this
study, cut-offs ≥6 for ADHD, ≥ 4.5 for ASD, and ≥ 0.5
for DCD with a sensitivity of (0.91/0.91/0.63) and a spe-
cificity of (0.73/0.80/0.68) were used as a screening cut-
off for ADHD, ASD, and DCD.
Psychiatric outcomes in late adolescence/young adulthood
A personal identification number, which is assigned to
all individuals living in Sweden either at birth or when
permanently moving to Sweden, enables linkage across
health and service registers. The Swedish National
Patient Register (NPR) includes all inpatient data from
1987, and outpatient data from 2001 and is coded ac-
cording to ICD-9 and 10 codes. The validity of the NPR
is continuously assessed. Several studies report high val-
idity and reliability of several disorders, e.g., bipolar dis-
order [28] and psychotic disorders [29]. The following
ICD-10 codes were retrieved for all participants and are
commonly referred to as ‘psychiatric outcomes’ in this
study: F10–19 (alcohol and drug misuse disorders), F20–
29 and F30–31 (psychotic disorders and bipolar disor-
ders were merged into one category), F32–39 (depressive
disorders), F40–41 (anxiety disorders), and X60–84 (sui-
cidal ideation and suicide attempts) including all sub-
groups. In our linkage, the NPR was updated until the
31st of December 2014. For each individual, we recorded
ICD-10 codes and age at first observed event. Any in-
dividual could have multiple outcomes but was still
analyzed separately for each outcome. The overlap
can be found in Additional file 1: Table S1. Further,
we calculated a sum of outcomes, yielding values be-
tween 0 and 5.
Sensitivity analysis and attrition
To assess whether missing values affected our estimates
and inferences, we used multiple imputation with
chained equations to handle missing values in variables,
as implemented in the R-package ‘mice’ [30]. Values
were imputed using a random forest approach. We ana-
lyzed the associations between self- and parental re-
ported anxiety and the 5 separate outcomes, as well as
the collapsed, for the Swedish sample. No significant
changes were found (Additional file 1: Table S2). Preva-
lence of psychiatric outcomes in individuals whose par-
ents responded only at age 9/12 but not at age 15,
versus those who responded at both assessment waves
are characterized in Additional file 1: Table S3. The
prevalence differed significantly in responders and non-
responders (4.2 and 8.5%, χ2 = 153.56, p < 0.001).
Statistical analyses
We excluded individuals with psychiatric outcomes
assigned before the age of 15 (N = 181) from all analyses
and used log-linear regression models with the total
number of psychiatric diagnoses (alcohol and drug
misuse disorders, anxiety disorders, bipolar/psychotic
disorders, depressive disorders) and suicidal ideation as
the dependent variable, and the total score of anxiety as
the independent variable (ranging from 0 to 10). Results
are presented as rate ratios (RR), i.e. the increase in rate
of the outcome, per unit increase in the exposure. Next,
we used Cox proportional hazard regression to regress
each of the specific psychiatric outcomes on anxiety (un-
adjusted model) and excluded individuals who were
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assigned the respective psychiatric outcome before the
age of 15. Results are presented as hazard ratios, i.e.
comparing the risk of the outcome in the exposed and
unexposed group while accounting for follow-up time.
Parental report and self-report in the independent vari-
able were analyzed separately. We entered ADHD, ASD,
and DCD cut-offs, as well as sex into the models as co-
variates in order to test for confounding.
A cluster-robust sandwich estimator was applied to
adjust the standard errors for the nested twin data. For
our collapsed outcome “any psychiatric outcome”, p <
0.05 was considered statistically significant. For the indi-
vidual psychiatric outcomes, i.e., alcohol and drug mis-
use disorders, anxiety disorders, bipolar/psychotic
disorders, depressive disorders, and suicidal ideation
(unadjusted and adjusted for ADHD, ASD, DCD, and
sex, yielding 10 tests), we set the statistical significance
threshold at p < 0.005 to account for multiple compari-
sons. Estimates for anxiety categories ‘borderline’ and
‘abnormal’ were calculated relative to the anxiety cat-
egory ‘normal’, which served as the reference category.
To account for unmeasured confounders, (a) we con-
ducted a within-twin analysis, which capitalizes on the
complete genetic relatedness of monozygotic twin pairs.
The design takes genetic and environmental confound-
ing into account by comparing the risk of the outcome
in twins differentially exposed (i.e., having different levels
of anxiety [31]), (b) we calculated the E-value, which is
the lowest point estimate of both the confounder associ-
ations and the measured covariates that needs to be
present in order for an (unmeasured) confounder to fully
explain the association [32].
Survival analyses and attributable fractions
We created survival curves based on the unadjusted
model using the R function ‘survfit’ from the package
‘survival’ [33]. We then estimated the total amount,
while adjusting for childhood ADHD, ASD, and DCD, as
well as sex, of psychiatric outcomes in late adolescence/
young adulthood that could be attributed to anxiety by
calculating the attributable fraction (AF) using the
‘AFcoxph’ function from the package ‘AF’ [34] in R. The
‘AFcoxph’ function allows the AF to vary over time and
thus renders it possible to estimate age-specific AFs. The
function estimates the model-based adjusted attributable
fraction from the Cox proportional hazard regression
model and is commonly used for data from cohort sam-
pling designs with time-to-event outcomes while adjust-
ing for potential confounders. All analyses were
performed in R version 3.5.1 [35].
Replication from the Netherlands Twin Register
The Young Netherlands Twin Register (YNTR) and
the Adult Netherlands Twin Register (ANTR) have
been described in detail elsewhere [36, 37]. The sam-
ple included twins who were born the 1st January
1985 to the 31st December 1999 and were part of
the YNTR. Nine thousand two hundred eleven twins
were assessed at age 14 and then followed up at age
16 and 18. The retention rate varied between 10 and
47%, depending on follow up, giving sample sizes be-
tween 914 and 4283. In order to mirror the analyses
from CATSS, we used the empirically based anxious/
depressed syndrome scale scored from the Youth
Self-Report [38] to create the exposure measure. The
distribution of anxiety levels was carried out in the
same fashion as in the main analyses (80% ‘normal’,
10% ‘borderline’, 10% ‘abnormal’). As outcomes, we
used the Achenbach DSM-oriented scales at age 16:
anxiety (“anxiety problems”, 6 items), and depression
(“affective problems”, 13 items) and 18: for bipolar/
psychotic disorders, we used the Adult Self-Report
(ASR) Thought Problems scale [39]. For alcohol and
drug misuse disorders, a total score of 16 or higher
on the World Health Organization’s Alcohol Use
Disorders Identification Test [40], implying high-
risk/harmful alcohol use, was used. For suicidal idea-
tion as an outcome, we used an individual question
from the survey in the ASR indicating suicidal idea-
tion: “I deliberately try to hurt or kill myself”, an-
swered with either “somewhat or sometimes” or
“very much so or often”. A dichotomization was
conducted at the 90th percentile for all scales to
classify individuals as screen-positive for the respect-
ive outcome. As covariates, the ten items ASD scales
at age 7, 10 and 12, developed by So et al. [41], and
the ten items Attention Problems scales at age 7, 10,
and 12, developed by Achenbach and Rescorla [38],
both from the Child Behavior Checklist, were
included. As the outcome variables in the NTR
consisted of self-report and we had no access to
follow-up time, we used logistic regression models to
estimate the association between exposure and out-
come and included ADHD and ASD cut-offs, as well
as sex, as covariates into the model. Results are pre-
sented as odds ratios. A cluster-robust sandwich esti-
mator was applied to adjust for standard errors for
the nested twin data. P < .05 was considered statisti-
cally significant. For the individual psychiatric out-
comes, i.e., high-risk/harmful alcohol use, anxiety,
thought problems, depression, and suicidal ideation
(unadjusted and adjusted for ADHD, ASD, and sex,
yielding 10 tests), we set the statistical significance
threshold at p < 0.005 to account for multiple com-
parisons. Estimates for anxiety categories ‘borderline’
and ‘abnormal’ were calculated relative to the anxiety
category ‘normal’, which served as the reference
category.
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Results
Descriptives
Table 1 shows the prevalence and distribution of psychi-
atric diagnoses and suicidal ideation in self-report and
parental report, among the three anxiety categories in
CATSS-15. One in every thirty-three twins who filled
out the SDQ received a registry-based psychiatric out-
come during the follow-up period. Anxiety disorders
were the most prevalent psychiatric outcome (1.4%),
followed by depressive disorders (1.3%), and alcohol and
drug misuse disorders (1.0%). Both for parental and self-
reports, individuals in the ‘borderline’ and ‘abnormal’
anxiety categories were overall more commonly assigned
a psychiatric outcome during the follow-up period, com-
pared to individuals in the ‘normal’ anxiety category.
Sex-specific prevalences and distribution of psychiatric
outcomes for the whole sample can be found in Add-
itional file 1: Table S4 and showed that females were
more commonly diagnosed with any psychiatric out-
come, anxiety disorders, and depressive disorders.
Regression analyses
Each one-point increase on the total score of anxiety at
age 15, based on self-report, corresponded to a 23% ele-
vation in the number of assigned psychiatric outcomes
(self-report: RR = 1.23, 95% CI 1.17–1.29; parental re-
port: RR = 1.37, 95% CI 1.31–1.42). This held also true
after adjusting for sex, ADHD, ASD, DCD in childhood
(self-report: RR = 1.20, 95% CI 1.14–1.27; parental re-
port: RR = 1.32, 95% CI 1.25–1.39).
Table 2 shows the associations between adolescent
anxiety categories and the various psychiatric outcomes
for parental and self-report retrieved from the Cox pro-
portional hazard ratio analyses. Adjusted HRs for the
outcome of any psychiatric diagnosis or suicidal ideation
were 1.73 (95% CI 1.20–2.49; self-report) and 2.32 (95%
CI 1.64–3.29; parental report) in the ‘borderline’ categor-
ies and 3.40 (95% CI 2.58–4.48; self-report) and 3.88
(95% CI 2.86–5.25; parental report) in the ‘abnormal’
anxiety categories. The ‘borderline’ and ‘abnormal’ anx-
iety categories across both sources of report were signifi-
cantly associated with anxiety disorders and depressive
disorders, with the exception of the ‘borderline’ categor-
ies for depressive disorders (both unadjusted and ad-
justed, self-report). Within-twin analyses conducted on
monozygotic twins primarily yielded non-significant ef-
fects, with very wide CI:s, for the association between
adolescent anxiety categories and psychiatric outcomes
(see Additional file 1: Table S5). Corresponding E-values
can be found in Additional file 1: Table S6 and showed
that, overall, the E-values were roughly twice as high as
all the significant hazard ratios, indicating that substan-
tial confounding must be present in order to completely
explain away the observed effect.
Survival analyses and attributable fractions
Survival curves were converted depicting cumulative in-
cidence conditioned on level of anxiety. Figure 1 shows
age-dependent cumulative incidence of any psychiatric
outcome in self-report and parental report in individuals
Table 1 Prevalence and distribution of psychiatric outcomes at follow up among ‘normal’, ‘borderline’ and ‘abnormal’ anxiety
categories at age 15 self-report and parental report
Anxiety category
Total N (%) Normal Borderline Abnormal
Self-report 12,324 (100) 9359 (75.9) 1099 (8.9) 1866 (15.1)
No psychiatric outcome 11,950 (97.0) 9139 (97.6) 1056 (96.1) 1755 (94.1)
Any psychiatric outcome 374 (3.0) 220 (2.4) 43 (3.9) 111 (5.9)
Alcohol and drug misuse disorders 126 (1.0) 93 (1.0) 14 (1.3) 19 (1.0)
Anxiety disorders 175 (1.4) 83 (0.9) 28 (2.5) 64 (3.4)
Bipolar/psychotic disorders 16 (0.1) 12 (0.1) 2 (0.2) 2 (0.1)
Depressive disorders 157 (1.3) 76 (0.8) 16 (1.5) 65 (3.5)
Suicidal ideation 40 (0.3) 23 (0.2) 4 (0.4) 13 (0.7)
Parental report 11,133 (100) 9230 (82.9) 829 (7.4) 1074 (9.6)
No psychiatric outcome 10,775 (96.8) 9023 (97.8) 782 (94.3) 970 (90.3)
Any psychiatric outcome 358 (3.2) 207 (2.2) 47 (5.7) 104 (9.7)
Alcohol and drug misuse disorders 117 (1.1) 82 (0.9) 11 (1.3) 24 (2.2)
Anxiety disorders 167 (1.5) 82 (0.9) 25 (3.0) 60 (5.6)
Bipolar/psychotic disorders 16 (0.1) 12 (0.1) 2 (0.2) 2 (0.2)
Depressive disorders 146 (1.3) 74 (0.8) 25 (3.0) 47 (4.4)
Suicidal ideation 36 (0.3) 22 (0.2) 3 (0.4) 11 (1.0)
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within the three anxiety categories. The overall cumula-
tive incidence for any outcome up to the end of follow-
up (age 21) for those who self-reported were 7, 15 and
25% in the ‘normal, ‘borderline’, and ‘abnormal’ group. A
similar pattern could be seen for parental reports. For
anxiety disorders specifically, the overall cumulative inci-
dence up to the end of follow-up was 5% in individuals
with ‘normal’ anxiety, 9% in individuals with ‘borderline’
anxiety and 17% in individuals with ‘abnormal’ anxiety
in individuals who self-reported. Estimates for all specific
psychiatric outcomes can be found in the additional ma-
terial (Additional files 2, 3, 4, 5, 6: Figures S1-S5). The
incidence of any psychiatric outcome increased steadily
for the ‘normal’ anxiety category, whereas ‘borderline’
Table 2 Associations between anxiety category at baseline and psychiatric outcome in self-report and parental report. Figures are
hazard ratios (95% confidence intervals)
Anxiety category
Unadjusted Adjusteda
Psychiatric outcome Normalb Borderline Abnormal Normalb Borderline Abnormal
Self-report
Any psychiatric outcome 1 1.90 (1.36–2.65) 3.72 (2.93–4.72) 1 1.73 (1.20–2.49) 3.40 (2.58–4.48)
Alcohol and drug misuse disorders 1 1.44 (0.82–2.54) 1.42 (0.87–2.32) 1 1.22 (0.62–2.38) 1.25 (0.69–2.25)
Anxiety disorders 1 3.35 (2.18–5.16) 5.74 (4.15–7.96) 1 2.67 (1.65–4.34) 4.92 (3.33–7.28)
Bipolar/psychotic disorders 1 1.61 (0.38–7.26) 1.18 (0.26–5.30) 1 1.90 (0.46–7.87) 1.54 (0.39–6.04)
Depressive disorders 1 2.03 (1.18–3.50) 6.14 (4.39–8.58) 1 1.58 (0.87–2.88) 4.79 (3.23–7.08)
Suicidal ideation 1 1.68 (0.58–4.85) 3.93 (2.05–7.55) 1 1.16 (0.35–3.84) 2.33 (1.04–5.22)
Parental report
Any psychiatric outcome 1 2.60 (1.88–3.59) 4.88 (3.78–6.29) 1 2.32 (1.64–3.29) 3.88 (2.86–5.25)
Alcohol and drug misuse disorders 1 1.55 (0.82–2.91) 2.85 (1.80–4.49) 1 1.54 (0.79–3.02) 2.15 (1.21–3.83)
Anxiety disorders 1 3.60 (2.30–5.64) 7.52 (5.36–10.56) 1 3.11 (1.92–5.04) 6.01 (4.05–8.93)
Bipolar/psychotic disorders 1 1.95 (0.43–8.71) 1.59 (0.35–7.17) 1 1.72 (0.38–7.75) 1.08 (0.30–3.87)
Depressive disorders 1 4.02 (2.57–6.29) 6.52 (4.43–9.61) 1 3.32 (2.05–5.37) 5.07 (3.20–8.03)
Suicidal ideation 1 1.57 (0.47–5.26) 4.88 (2.37–10.07) 1 1.61 (0.46–5.63) 3.76 (1.62–8.72)
a Adjusted for sex, attention-deficit/hyperactivity disorder, autism spectrum disorder, and developmental coordination disorder at age 9/12. Bold estimates
indicate significance at the 0.005 level, except for ‘any psychiatric outcome’, where alpha was set to 0.05.
b Reference category
Fig. 1 Cumulative incidence of any psychiatric outcome in individuals within ‘normal’, ‘borderline’, and ‘abnormal’ anxiety categories at age 15 in
self-report and parental report. Note. For representational purposes, figures were cut at age 21
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and ‘abnormal’ anxiety categories increased steeply, with
a possible inflection point occurring around 19 years of
age.
Figure 2 displays the attributable fractions (AFs) for
any psychiatric outcome until late adolescence/young
adulthood that is attributable to ‘borderline’ and ‘abnor-
mal’ adolescence anxiety at age 15 in self-report and
parental report, suggesting that, over time, 29% of the
occurrence of any psychiatric outcome is attributable to
prior adolescent anxiety (self-report). Consistent with
the magnitude of the HRs for specific outcomes, the
highest AFs were found for anxiety disorders (AF 43–
40%), depressive disorders (AF 39–38%), and suicidal
ideation (AF 21%, all self-report; see additional material
for (Additional files 7, 8, 9, 10, 11: Figures S6-S10 on all
specific outcomes).
Replication in the NTR
Prevalence and distributions from the NTR are reported
in Additional file 1: Table S7 in the additional material.
High prevalences were found for thought problems, anx-
iety, and depression. The results from the log-linear re-
gression analysis showed a similar pattern as in CATSS,
both in the unadjusted model (RR = 1.18, 95% CI 1.17–
1.19), and when adjusted for sex, ADHD and ASD in
childhood (RR = 1.16, 95% CI 1.15–1.17). Results from
the logistic regression models were similar to what was
seen in the CATSS albeit with stronger associations, i.e.
the highest risks were found in the ‘abnormal’, followed
by the ‘borderline’ category, for anxiety (OR = 14.02, 95%
CI 10.38–18.93), and depression (OR = 8.00, 95% CI
5.93–10.79; see Additional file 1: Table S8 for all specific
outcomes).
Discussion
In this population-based longitudinal study, adolescent
anxiety, of various levels, was found to elevate the risk of
developing a range of subsequent psychiatric outcomes
in late adolescence/young adulthood. Highest risk eleva-
tions were found for anxiety disorders (7.52), depressive
disorders (6.52), any psychiatric outcome (4.88), and sui-
cidal ideation (4.88). All associations remained virtually
unaltered after adjusting for ADHD, ASD, and DCD.
Risk patterns between anxiety in adolescence and later
psychiatric outcomes were mirrored in the Dutch sam-
ple, regardless of differences in reports and instruments.
Incidence patterns revealed distinct properties of the
three anxiety categories that affected the risk of develop-
ing psychiatric outcomes. Namely, there was steep, in-
creased risk for the ‘borderline’ and ‘abnormal’ anxiety
categories. Cumulative incidence was highest in the ‘ab-
normal’ anxiety category for any psychiatric outcome
(25%), anxiety disorders (17%), alcohol and drug misuse
disorders (12%), and depressive disorders (10%). For
both individuals in the ‘borderline’ and ‘abnormal’ anx-
iety group, the proportion of psychiatric outcome that
could theoretically be avoided if adolescent anxiety was
prevented or treated early was highest for anxiety disor-
ders and depressive disorders (~ 40%). AFs further indi-
cate that adolescence anxiety accounted for up to a third
of any assessed psychiatric diagnosis in late adolescence/
young adulthood.
Our finding that adolescent anxiety predicts young
adult psychiatric outcomes beyond the risk conferred by
childhood ADHD, ASD and DCD was not anticipated.
These constructs are generally stronger predictors for
psychiatric outcomes than anxiety [16, 17] and the
Fig. 2 Attributable fraction of any psychiatric outcome in individuals within ‘borderline’ and ‘abnormal’ anxiety categories at age 15 in self−report
and parental report. Note. Dashed lines represent 95% confidence intervals. For representational purposes, figures were cut at age 21
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onset almost always precedes that of anxiety disorders.
In a recent study, Rice et al. [42] delineated two age of
onset based trajectories to Major Depressive Disorder.
The early-adolescence onset group was associated with a
genetic risk for neurodevelopmental disorders, while the
later-adolescence-onset group was associated with gen-
etic risk for Major Depressive Disorder only. We there-
fore conducted additional post-hoc analyses including
the 181 individuals who received their diagnosis before
the age of 15. No meaningful difference could be dis-
cerned (HR for any outcome, ‘abnormal’ anxiety cat-
egory, self-report: 3.45; parental report: 4.77) suggesting
that our results were not confounded by the exclusion of
a possible early-adolescence onset group characterized
by neurodevelopmental disorder susceptibility.
The ‘borderline’ anxiety categories predicted a broad
range of our assessed outcomes in late adolescence/
young adulthood. That is, at group level, adolescents in
the ‘borderline’ anxiety category both had an earlier on-
set and higher rates of early adult psychiatric outcomes.
This suggests that a screening based on symptom pres-
entation of anxiety rather than on full diagnostic criteria
should always be conducted in clinical settings, irre-
spective of the focus of the assessment. Clinicians should
remain vigilant towards those reporting elevated levels
of anxiety, as incidence patterns for the specific psychi-
atric outcomes for the ‘borderline’ anxiety group were all
characterized by steep curves.
The incidence of psychiatric outcomes were roughly
evenly distributed over time, suggesting that there is
no clearly identifiable time point when an individual
with elevated levels of anxiety is susceptible to be di-
agnosed with a psychiatric disorder. In self-report
data from ages 15 to 17, the ‘borderline’ anxiety
group could not be distinguished from the ‘normal’
anxiety group, so parental report might therefore be
preferable in clinical settings for this age group in
order to identify individuals with an elevated risk for
psychiatric outcomes based on their levels of anxiety.
While a more detailed delineation of trajectories of
individuals with anxiety is undoubtedly necessary, five
questions administered at age 15 were sufficient to
prospectively identify a third of all assessed psychi-
atric outcomes. Studies on the efficacy of treatment
for anxiety disorders have reported an observed re-
duction in associated symptomatology and comorbid-
ity, including depression, and other anxiety disorders
[43, 44]. Thus, it is possible that treatments directed
towards the core symptoms of anxiety in adolescence
may attenuate the risk and affect the trajectories
leading into a wide array of psychiatric outcomes (i.e.
anxiety disorders, depressive disorders, alcohol and
drug misuse disorders, possibly also bipolar/psychotic
disorders) and suicidal ideation. As a final note, even
though the within-twin design was underpowered and
accompanied by very wide CI:s, the results may
indicate that the association between anxiety and psy-
chiatric outcomes can be confounded by shared envir-
onmental and/or genetic factors. This highlights the
importance of studying the development of anxiety
using genetically sensitive designs.
The study has several strengths which include large
sample sizes, high response rates, the use of a validated
assessment instrument, the usage of two independent
population-based samples, and finally, linkage to a
nation-wide register, which offers the possibility to
analyze anxiety and psychiatric outcomes with little or
no shared method variance, while also circumventing
the problem of attrition.
The results also have to be interpreted in the light
of limitations. Participants were followed up until ei-
ther the occurrence of the first psychiatric outcome
or when the coverage of the NPR entries ended,
around the age of 22 for the oldest participants.
Thus, the rate of false negatives might be elevated. As
a consequence, the estimates for disorders which gen-
erally have a later mean age of onset, e.g., bipolar and
psychotic disorders, should therefore be interpreted
with caution. Related, the NPR only includes diagno-
ses in out or in-patient care, why diagnoses assigned
in primary care, reasonably those with less profound
symptomatology, are not included in the analyses.
Difference in response rate from ages 9 and 15 may
have affected the observed association, as reflected in
the attrition analyses. Thus, the generalizability should
be interpreted with caution. We can only speculate
about the direction of the effect but it seems plausible
that, if anything, it attenuated the observed associa-
tions. Finally, some exposure misclassification should
be expected as the SDQ does not have perfect sensi-
tivity and specificity nor does the anxiety category
‘abnormal’ equate a clinical construct as, for instance,
the duration of the distress and impairment arising
from the symptoms are not assessed or accounted
for. This is evident as prevalence estimates from epi-
demiological studies generally are higher than clinical
estimates [45].
Conclusion
In conclusion, the results of the present study suggest
that anxiety in adolescence constitutes an important risk
factor in the development of psychiatric diagnoses and
suicidal ideation, and revealed unique predictions for the
different levels of anxiety, and beyond the risk conferred
by childhood ADHD, ASD and DCD. This emphasizes
the need to further empirically investigate developmental
trajectories leading from neurodevelopmental disorders
and anxiety into adverse outcomes later in life.
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